ifosfamide has been researched along with Nerve Sheath Neoplasms in 11 studies
Nerve Sheath Neoplasms: Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prognosis of metastatic malignant peripheral nerve sheath tumor (MPNST) is poor and the role of chemotherapy is controversial." | 1.56 | Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy. ( Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J, 2020) |
| "Malignant peripheral nerve sheath tumors (MPNST) are rare soft-tissue sarcomas with a tendency for recurrence and metastasis." | 1.37 | Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. ( Crawford, EA; Lackman, RD; Moretti, VM; Ogilvie, CM; Staddon, AP, 2011) |
| " In the previous five cycles of ifosfamide, carboplatin, and etoposide, the patient had no problems with the neurotoxic adverse effects associated with ifosfamide use." | 1.35 | Possible contribution of aprepitant to ifosfamide-induced neurotoxicity. ( Jarkowski, A, 2008) |
| " The bioavailability is nearly 100% after oral application, and the main metabolites are 4-hydroxytrofosfamide, and 4-hydroxyifosfamide." | 1.32 | Hypersensitivity pneumonitis associated with the use of trofosfamide. ( Hartmann, JT; Kanz, L; Kopp, HG, 2004) |
| "Malignant peripheral nerve sheath tumors (MPNST) are uncommon tumors of cells of peripheral nerve sheath origin." | 1.32 | Intraosseous malignant peripheral nerve sheath tumor (MPNST) of the thoracic spine: a rare cause of spinal cord compression. ( Bhattacharjee, S; Gnanalingham, K; O'Neill, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, T | 1 |
| Sahu, S | 1 |
| Sharma, MC | 1 |
| Borkar, S | 1 |
| Wang, Y | 1 |
| Katagiri, H | 1 |
| Murata, H | 1 |
| Wasa, J | 1 |
| Miyagi, M | 1 |
| Kakuda, Y | 1 |
| Takahashi, M | 1 |
| Pannu, AK | 1 |
| Sharma, N | 1 |
| Jarkowski, A | 1 |
| Zambrana, F | 1 |
| Vicente, F | 1 |
| García-Manrique, T | 1 |
| Pereira, S | 1 |
| Sáinz De Zaitigui, J | 1 |
| De La Cruz Merino, L | 1 |
| Moretti, VM | 1 |
| Crawford, EA | 1 |
| Staddon, AP | 1 |
| Lackman, RD | 1 |
| Ogilvie, CM | 1 |
| Cuneo, KC | 1 |
| Riedel, RF | 1 |
| Dodd, LG | 1 |
| Harpole, DH | 1 |
| Kirsch, DG | 1 |
| Masui, F | 1 |
| Yokoyama, R | 1 |
| Soshi, S | 1 |
| Beppu, Y | 1 |
| Asanuma, K | 1 |
| Fujii, K | 1 |
| Kopp, HG | 1 |
| Kanz, L | 1 |
| Hartmann, JT | 1 |
| Gnanalingham, K | 1 |
| Bhattacharjee, S | 1 |
| O'Neill, K | 1 |
| Schafmayer, C | 1 |
| Egberts, JH | 1 |
| Kovács, G | 1 |
| Leuschner, I | 1 |
| Tepel, J | 1 |
11 other studies available for ifosfamide and Nerve Sheath Neoplasms
| Article | Year |
|---|---|
Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report.
Topics: Burkitt Lymphoma; Cytarabine; Humans; Ifosfamide; Male; Middle Aged; Nerve Sheath Neoplasms; Treatme | 2022 |
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; M | 2020 |
Neurofibromatosis type 1 and disseminated malignant peripheral nerve sheath tumor.
Topics: Antineoplastic Agents; Cafe-au-Lait Spots; Disease Management; Doxorubicin; Humans; Ifosfamide; Lung | 2017 |
Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Dexamet | 2008 |
Primary intracranial malignant peripheral nerve sheath tumour responding to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Doxorubicin; Humans; Ifosfam | 2010 |
Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; | 2011 |
Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.
Topics: Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Neoadjuv | 2012 |
A malignant peripheral nerve-sheath tumour responding to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Cyclophosphamide; Doxorubicin; Hum | 2004 |
Hypersensitivity pneumonitis associated with the use of trofosfamide.
Topics: Administration, Oral; Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Pro | 2004 |
Intraosseous malignant peripheral nerve sheath tumor (MPNST) of the thoracic spine: a rare cause of spinal cord compression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Chemotherapy, Adjuvant; Combined | 2004 |
[Emergent treatment of a malignant peripheral epineurial tumour].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2006 |